Not Yet a Biotech Empire

In the pipelineNumber of drugs in development by New York companiesEmploymentNumber of biotechnology employees in New York††Includes only those companies still in existence or operating in the state in 2002Facts and figures• New York is home to 101 biotechnology companies, more than half of which focus on the development of new therapeutic products and related drug-delivery technologies• For every public biotech company in New York state, there are about three private one

Written byFrancesco Fiondella
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Number of drugs in development by New York companies

Number of biotechnology employees in New York

Includes only those companies still in existence or operating in the state in 2002

New York is home to 101 biotechnology companies, more than half of which focus on the development of new therapeutic products and related drug-delivery technologies

For every public biotech company in New York state, there are about three private ones

The public companies within this group have a combined market capitalization of approximately $8.6 billion

Source: New York Biotechnology Assoc., "2004 State of the Industry Report"

- Francesco Fiondella

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery